The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans

European Journal of Clinical Nutrition

Volumn 71, Issue 2, 2017, Pages 227-233

  Rahat Rozenbloom, S ^a   Fernandes, J ^a   Cheng, J ^b   Gloor, G B ^c   Wolever, T M S ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; C PEPTIDE; FATTY ACID; GLUCOSE; INSULIN; INULIN; PROPIONIC ACID; RESISTANT STARCH; SHORT CHAIN FATTY ACID; STARCH; UNCLASSIFIED DRUG; VOLATILE FATTY ACID;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; INSULIN RESPONSE; MALE; NORMAL HUMAN; OBESITY; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; BLOOD; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; IDEAL BODY WEIGHT; MEAL; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; FATTY ACIDS, VOLATILE; FEMALE; HUMANS; IDEAL BODY WEIGHT; INSULIN; INULIN; MALE; MEALS; MIDDLE AGED; OVERWEIGHT; POSTPRANDIAL PERIOD; STARCH; YOUNG ADULT;

EID: 85006276984     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2016.248     Document Type: Article

References (48)

1. Weickert MO, Pfeiffer AFH. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008; 138: 439-442.
2. Nilsson A, Granfeldt Y, Östman E, Preston T, Björck I. Effects of GI and content of indigestible carbohydrates of cereal-based evening meals on glucose tolerance at a subsequent standardised breakfast. Eur J Clin Nutr 2006; 60: 1092-1099.
3. Wolever TMS, Bentum-Williams A, Jenkins DJA. Physiological modulation of plasma free fatty acid concentrations by diet: metabolic implications in nondiabetic subjects. Diabetes Care 1995; 18: 962-970.
4. Nilsson A, Östman E, Preston T, Björck I. Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr 2008; 62: 712-720.
5. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008; 149: 4519-4526.
6. Yamashita H, Fujisawa K, Ito E, Idei S, Kawaguchi N, Kimoto M et al. Improvement of obesity and glucose tolerance by acetate in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biosci Biotechnol Biochem 2007; 71: 1236-1243.
7. Crouse JR, Gerson CD, DeCarli LM, Lieber CS. Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. J Lipid Res 1968; 9: 509-512.
8. Wolever TMS, Brighenti F, Royall D, Jenkins AL, Jenkins DJA. Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol 1989; 84: 1027-1033.
9. Brighenti F, Benini L, Del Rio D, Casiraghi C, Pellegrini N, Scazzina F et al. Colonic fermentation of indigestible carbohydrates contributes to the second-meal effect. Am J Clin Nutr 2006; 83: 817-822.
10. Tarini J, Wolever TMS. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 2010; 35: 9-16.
11. Slavin J, Stewart M, Timm D, Grabitske H, Hospattankar A. Fermentation patterns and short chain fatty acid profiles of wheat dextrin and other functional fibres. In: Dietary Fibre: New Frontiers for Food and Health, 2010, pp 177-191.
12. Jenkins DJA, Vuksan V, Kendall CWC, Würsch P, Jeffcoat R, Waring S et al. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr 1998; 17: 609-616.
13. Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabetic Med 2010; 27: 391-397.
14. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005; 82: 559-567.
15. Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 2003; 46: 659-665.
16. Robertson MD, Wright JW, Loizon E, Debard C, Vidal H, Shojaee-Moradie F et al. Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. J Clin Endocrinol Metab 2012; 97: 3326-3332.
17. Diez M, Hornick JL, Baldwin P, Istasse L. Influence of a blend of fructooligosaccharides and sugar beet fiber on nutrient digestibility and plasma metabolite concentrations in healthy Beagles. Am J Vet Res 1997; 58: 1238-1242.
18. Rozan P, Nejdi A, Hidalgo S, Bisson JF, Desor D, Messaoudi M. Effects of lifelong intervention with an oligofructose-enriched inulin in rats on general health and lifespan. Br J Nutr 2008; 100: 1192-1199.
19. Diez M, Hornick JL, Baldwin P, Van Eenaeme C, Istasse L. The influence of sugarbeet fibre, guar gum and inulin on nutrient digestibility, water consumption and plasma metabolites in healthy Beagle dogs. Res Vet Sci 1998; 64: 91-96.
20. Beylot M. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 2005; 93(Suppl): S163-S168.
21. Bonsu NK, Johnson CS, Mcleod KM. Can dietary fructans lower serum glucose? J Diabetes 2011; 3: 58-66.
22. Raninen K, Lappi J, Mykkänen H, Poutanen K. Dietary fiber type reflects physiological functionality: comparison of grain fiber, inulin, and polydextrose. Nutr Rev 2011; 69: 9-21.
23. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075.
24. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesityassociated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
25. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18: 190-195.
26. Fernandes J, Su W, Rahat-Rozenbloom S, Wolever TMS, Comelli EM. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes 2014; 4: e121.
27. Teixeira TFS, Grześkowiak L, Franceschini SCC, Bressan J, Ferreira CLLF, Peluzio MCG. Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br J Nutr 2013; 109: 914-919.
28. Murugesan S, Ulloa-Martínez M, Martínez-Rojano H, Galván-Rodríguez FM, Miranda-Brito C, Romano MC et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J Clin Microbiol Infect Dis 2015; 34: 1337-1346.
29. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009; 4: e7125.
30. Santacruz A, Collado MC, García-Valdés L, Segura MT, Marítn-Lagos JA, Anjos T et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 2010; 104: 83-92.
31. Furet J-, Kong L-, Tap J, Poitou C, Basdevant A, Bouillot J et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010; 59: 3049-3057.
32. Ainsworth BE, Haskell WL, Leon AS, Jacobs Jr DR, Montoye HJ, Sallis JF et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71-80.
33. Pereira MA, Fitzer Gerald SJ, Gregg EW, Joswiak ML, Ryan WJ, Suminski RR et al. A Collection of Physical Activity Questionnaires for Health-Related Research. Modifiable Activity Questionnaire. Med Sci Sports Exerc 1997; 29(Suppl): S73-S78.
34. Rahat-Rozenbloom S, Fernandes J, Gloor GB, Wolever TMS. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int J Obes 2014; 38: 1525-1531.
35. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013; 1: 3.
36. Gloor GB, Reid G. Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data. Can J Microbiol 2016; 62: 692-703.
37. Fernandes J, Vogt J, Wolever TMS. Inulin increases short-term markers for colonic fermentation similarly in healthy and hyperinsulinaemic humans. Eur J Clin Nutr 2011; 65: 1279-1286.
38. Freeland KR, Wilson C, Wolever TMS. Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 2010; 103: 82-90.
39. James SL, Muir JG, Curtis SL, Gibson PR. Dietary fibre: a roughage guide. Intern Med J 2003; 33: 291-296.
40. Yang J, Martínez I, Walter J, Keshavarzian A, Rose DJ. Invitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. Anaerobe 2013; 23: 74-81.
41. Bodinham CL, Smith L, Thomas EL, Bell JD, Swann JR, Costabile A et al. Efficacy of increased resistant starch consumption in human type 2 diabetes. Endocr Connect 2014; 3: 75-84.
42. Klosterbuer AS, Thomas W, Slavin JL. Resistant starch and pullulan reduce postprandial glucose, insulin, and GLP-1, but have no effect on satiety in healthy humans. J Agric Food Chem 2012; 60: 11928-11934.
43. Jenkins DJA, Wolever TMS, Ocana AM, Vuksan V, Cunnane SC, Jenkins M et al. Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping. Diabetes 1990; 39: 775-781.
44. Christensen NJ, Ørskov H, Hansen AP. Significance of glucose load in oral glucose tolerance tests. Acta Med Scand 1972; 192: 337-342.
45. Bodinham CL, Al-Mana NM, Smith L, Robertson MD. Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption. Br J Nutr 2013; 110: 1429-1433.
46. Fernandes J, Vogt J, Wolever TMS. Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans. Eur J Clin Nutr 2012; 66: 1029-1034.
47. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014; 156: 84-96.
48. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R et al. Human genetics shape the gut microbiome. Cell 2014; 159: 789-799.